Repligen (RGEN) Income from Continuing Operations (2010 - 2026)
Repligen (RGEN) posted quarterly Income from Continuing Operations of 5008000.0 for Q2 2026, down 66.31% year-over-year from 14866000.0 in Q2 2025, and down 40.18% quarter-over-quarter from 8372000.0 in Q1 2026.
Repligen (RGEN) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Income from Continuing Operations for 17 consecutive years, with 5008000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Income from Continuing Operations fell 66.31% year-over-year to 5008000.0; the TTM figure through Jun 2026 stood at 61753000.0 (up 166.64% YoY), while the FY2025 annual figure was 69032000.0, up 166.15% from the prior year.
- Income from Continuing Operations declined to 5008000.0 in Q2 2026 per RGEN's latest filing, from 8372000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 49861000.0 in Q2 2022 and bottomed at 112713000.0 in Q4 2024.
- Historically, Income from Continuing Operations has averaged 11758944.44 across 5 years, with a median of 14888500.0 in 2025.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations sank 1435.78% — and 2025, when it surged 2379.97%.
- Repligen's Income from Continuing Operations stood at 35890000.0 in 2022, then tumbled by 76.49% to 8438000.0 in 2023, then tumbled by 1435.78% to 112713000.0 in 2024, then surged by 129.69% to 33462000.0 in 2025, then plunged by 85.03% to 5008000.0 in 2026.
- Business Quant data shows RGEN's Income from Continuing Operations at 5008000.0 in Q2 2026, 8372000.0 in Q1 2026, and 33462000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 5.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.01 Mn |
| Mar 31, 2026 | 8.37 Mn |
| Dec 31, 2025 | 33.46 Mn |
| Sep 30, 2025 | 14.91 Mn |
| Jun 30, 2025 | 14.87 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | -112.71 Mn |
| Sep 30, 2024 | -654,000.00 |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 8.44 Mn |
| Sep 30, 2023 | 16.92 Mn |
| Jun 30, 2023 | 19.79 Mn |
| Mar 31, 2023 | 15.34 Mn |
| Dec 31, 2022 | 35.89 Mn |
| Sep 30, 2022 | 40.41 Mn |
| Jun 30, 2022 | 49.86 Mn |
| Mar 31, 2022 | 46.93 Mn |
| Dec 31, 2021 | 22.12 Mn |
| Sep 30, 2021 | 33.50 Mn |